FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1979486180> ?p ?o ?g. }

• W1979486180 endingPage "288" @default.
• W1979486180 startingPage "283" @default.
• W1979486180 abstract "Efficacy of octreotide treatment for Graves' ophthalmopathy (GO) and the effects of this treatment on the serum levels of the circulating intercellular adhesion molecule-1 (sICAM-1) were evaluated. Ten patients with GO were treated with octreotide three daily SC injections of 100 μg, for 3 months. Octreotide treatment was initiated after restoration of euthyroidism with antithyroid drugs. All patients were treated with methimazole to maintain euthyroidism during the study. Sera were collected from all patients before and 3 months after initiation of the study, and from 20 age- and sex-matched healthy subjects for sICAM-1 measurement. sICAM-1 was measured by a sandwich ELISA method. Proptosis in all patients was evaluated by orbital CT scan before and 3 months after initiation of the study. Two of 10 patients did not respond to octreotide therapy, while the remaining eight patients showed regression or improvement after therapy. Octreotide therapy was particularly successful in patients with soft tissue involvement of GO (class II or III disease). Mean proptosis and ophthalmopathy index scores were significantly decreased after 3 months of octreotide therapy. Mean sICAM-1 levels were significantly higher in patients before octreotide therapy (470.5 ± 52.6 ng/mL, p < 0.0001) when compared to normal subjects (186.5 ± 53.3 ng/mL). Mean sICAM-1 levels were significantly decreased 3 months after octreotide therapy (from 478.7 ± 52.6 to 415 ± 42.8 ng/mL, p = 0.012) in the 8 patients who responded to therapy. In contrast, sICAM-1 levels remained unchanged or increased in two patients with poor response to octreotide therapy. Our results suggest that octreotide therapy could be a treatment modality in patients with GO. The mechanism by which octreotide acts on GO is not clear. The observed decrease in sICAM-1 levels during octreotide therapy suggests that octreotide may have immunomodulatory properties. Further investigation is needed to determine the optimal dose and duration of octreotide therapy." @default.
• W1979486180 created "2016-06-24" @default.
• W1979486180 creator A5027903902 @default.
• W1979486180 creator A5033520812 @default.
• W1979486180 creator A5037231511 @default.
• W1979486180 creator A5047562398 @default.
• W1979486180 creator A5048975588 @default.
• W1979486180 creator A5067570475 @default.
• W1979486180 creator A5086745004 @default.
• W1979486180 date "1996-08-01" @default.
• W1979486180 modified "2023-10-17" @default.
• W1979486180 title "Effects of Octreotide Treatment on Graves' Ophthalmopathy and Circulating sICAM-1 Levels" @default.
• W1979486180 cites W1966286149 @default.
• W1979486180 cites W1972949074 @default.
• W1979486180 cites W1981297743 @default.
• W1979486180 cites W1993478023 @default.
• W1979486180 cites W1993989844 @default.
• W1979486180 cites W2005518939 @default.
• W1979486180 cites W2005895248 @default.
• W1979486180 cites W2008394246 @default.
• W1979486180 cites W2010900744 @default.
• W1979486180 cites W2014105565 @default.
• W1979486180 cites W2020319987 @default.
• W1979486180 cites W2021192826 @default.
• W1979486180 cites W2022205162 @default.
• W1979486180 cites W2027553609 @default.
• W1979486180 cites W2029602665 @default.
• W1979486180 cites W2032616751 @default.
• W1979486180 cites W2036852612 @default.
• W1979486180 cites W2041452685 @default.
• W1979486180 cites W2051104028 @default.
• W1979486180 cites W2051393146 @default.
• W1979486180 cites W2055975024 @default.
• W1979486180 cites W2070866454 @default.
• W1979486180 cites W2077973993 @default.
• W1979486180 cites W2089992103 @default.
• W1979486180 cites W2091950481 @default.
• W1979486180 cites W2097400518 @default.
• W1979486180 cites W2139030289 @default.
• W1979486180 cites W2320293007 @default.
• W1979486180 cites W2334870842 @default.
• W1979486180 cites W4229901843 @default.
• W1979486180 cites W4229947782 @default.
• W1979486180 cites W4255653789 @default.
• W1979486180 cites W4255804718 @default.
• W1979486180 doi "https://doi.org/10.1089/thy.1996.6.283" @default.
• W1979486180 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8875747" @default.
• W1979486180 hasPublicationYear "1996" @default.
• W1979486180 type Work @default.
• W1979486180 sameAs 1979486180 @default.
• W1979486180 citedByCount "36" @default.
• W1979486180 countsByYear W19794861802014 @default.
• W1979486180 countsByYear W19794861802015 @default.
• W1979486180 countsByYear W19794861802016 @default.
• W1979486180 countsByYear W19794861802017 @default.
• W1979486180 countsByYear W19794861802018 @default.
• W1979486180 crossrefType "journal-article" @default.
• W1979486180 hasAuthorship W1979486180A5027903902 @default.
• W1979486180 hasAuthorship W1979486180A5033520812 @default.
• W1979486180 hasAuthorship W1979486180A5037231511 @default.
• W1979486180 hasAuthorship W1979486180A5047562398 @default.
• W1979486180 hasAuthorship W1979486180A5048975588 @default.
• W1979486180 hasAuthorship W1979486180A5067570475 @default.
• W1979486180 hasAuthorship W1979486180A5086745004 @default.
• W1979486180 hasConcept C126322002 @default.
• W1979486180 hasConcept C134018914 @default.
• W1979486180 hasConcept C2776297358 @default.
• W1979486180 hasConcept C2776652619 @default.
• W1979486180 hasConcept C2779134260 @default.
• W1979486180 hasConcept C2781025020 @default.
• W1979486180 hasConcept C71924100 @default.
• W1979486180 hasConcept C90924648 @default.
• W1979486180 hasConceptScore W1979486180C126322002 @default.
• W1979486180 hasConceptScore W1979486180C134018914 @default.
• W1979486180 hasConceptScore W1979486180C2776297358 @default.
• W1979486180 hasConceptScore W1979486180C2776652619 @default.
• W1979486180 hasConceptScore W1979486180C2779134260 @default.
• W1979486180 hasConceptScore W1979486180C2781025020 @default.
• W1979486180 hasConceptScore W1979486180C71924100 @default.
• W1979486180 hasConceptScore W1979486180C90924648 @default.
• W1979486180 hasIssue "4" @default.
• W1979486180 hasLocation W19794861801 @default.
• W1979486180 hasLocation W19794861802 @default.
• W1979486180 hasOpenAccess W1979486180 @default.
• W1979486180 hasPrimaryLocation W19794861801 @default.
• W1979486180 hasRelatedWork W2013777072 @default.
• W1979486180 hasRelatedWork W2020299418 @default.
• W1979486180 hasRelatedWork W2029726031 @default.
• W1979486180 hasRelatedWork W2046753666 @default.
• W1979486180 hasRelatedWork W2052818326 @default.
• W1979486180 hasRelatedWork W2103307877 @default.
• W1979486180 hasRelatedWork W2131564031 @default.
• W1979486180 hasRelatedWork W2131979641 @default.
• W1979486180 hasRelatedWork W2151397963 @default.
• W1979486180 hasRelatedWork W2335272111 @default.
• W1979486180 hasVolume "6" @default.
• W1979486180 isParatext "false" @default.
• W1979486180 isRetracted "false" @default.

• next